Skip to main content
Download PDF

Age of Hypertension Onset: Overview of Research and How to Apply in Practice

Current Hypertension Reports volume 22, Article number: 68 (2020) Cite this article

Abstract

Purpose of Review

To review the current evidence on research related to age of hypertension onset—its definition, correlates, heritability, and association with adverse outcomes. We also propose a framework for implementing assessment of hypertension onset age into clinical practice.

Recent Findings

Prior studies have used both objective measurements and self-report to determine age of hypertension onset or early-onset hypertension. Yet, no criterion for standard definition currently exists for either. Data from epidemiological and clinical studies demonstrate that early-onset hypertension is a highly heritable trait that confers an increased risk for cardiovascular death and end-organ damage compared with late-onset hypertension.

Summary

Literature to date suggests that (parental) age of hypertension onset can be feasibly assessed for estimating (1) risk of future hypertension in non-hypertensive persons; and (2) the propensity for cardiovascular disease in individuals with established hypertension.

Introduction

Elevated blood pressure (BP) affects over 1 billion people globally and is known to be highly age-dependent [1,2,3,4,5]. The patterns of BP progression over age in the general population are well-documented. On average, systolic BP (SBP) rises throughout life in most individuals and finally reaches a plateau in late life [6]. However, BP trajectories over age can vary and are likely related to different levels of cardiovascular risk [7, 8]. Particularly, younger hypertensive individuals, who are more likely to be undiagnosed and undertreated than older patients, are at high risk of lifetime cardiovascular disease [9]. Despite chronological age being the strongest risk factor for both hypertension and cardiovascular disease, limited focus has been given until recently to age of hypertension onset as a potential risk factor in patients.

Several prior studies have examined age of disease onset and its impact on adverse outcomes in the context of chronic diseases, such as diabetes and obesity [10,11,12,13]. These studies have concluded that early disease onset usually results in a considerably poorer prognosis than late onset. Despite the similarities between hypertension, diabetes, and obesity as chronic disease states, the prognosis and clinical relevance of hypertension that begins in early versus late life have remained mainly unknown. Previous studies have introduced several indices for assessing an individual’s long-term BP exposure, such as time-averaged BP, cumulative BP, and BP trajectory patterns [14••, 15,16,17]. In all of these studies, long-term BP exposure was more closely associated with adverse outcomes than single BP measurements. However, these indices usually require complex calculations and availability of a large number of historical BP recordings, limiting their implementation into everyday clinical practice. Thus, more feasible risk stratification methods are called for to better estimate the long-term lifetime exposure to high BP in hypertensive patients.

The current hypertension treatment guidelines do not consider age of hypertension onset in the management of hypertensive individuals [18, 19]. However, a growing literature suggests that it may be important to distinguish between early-onset and late-onset hypertension as a familial trait when assessing an individual’s risk for hypertension, and as a specific type of BP trait when estimating risk for cardiovascular outcomes in individuals with established hypertension. This review will summarize current evidence on research related to age of hypertension onset—its definition, correlates, heritability, and association with adverse outcomes. We also propose a framework for implementing assessment of hypertension onset age into clinical practice.

Definition of Hypertension Onset Age

Three methods have been used in prior epidemiological and clinical studies to derive information on the age at which an individual’s BP level meets the criteria for hypertension for the first time: serial BP measurements, medical records, or self-report. Objective BP measurements have been the most commonly used method in epidemiological studies, such as the Framingham Heart Study or the Johns Hopkins Precursors Study. In these studies, standardized, repeated BP measurements performed at regular intervals are usually available, making it possible to objectively define the time and age of hypertension onset [8, 20•, 21••, 22, 23•]. In several of these studies, hypertension was defined as SBP/diastolic BP (DBP) ≥ 140/90 mmHg or use of antihypertensive medication at two or more consecutively attended examinations. This definition has been used for to reduce variation and to represent a more durable change in BP [8, 21••, 22, 23•]. However, in other studies, only one instance of elevated BP was required for hypertension onset [20•].

Apart from epidemiological studies, some cross-sectional observational studies have also used documented BP reports or medical records for determining hypertension onset age [20•, 24]. In contrast, most clinical studies, in which long-term BP data are not usually available, have defined hypertension onset using self-reported age at when the patient was first diagnosed or treated for hypertension [20•, 24, 25•, 26, 27, 28••, 29]. The latter two methods for defining hypertension onset (medical records and self-report) are markedly different from the former (objective BP measurements). Information from medical records and self-report mainly reflects the age of diagnosis instead of the true age of onset derived from repeated, objective measurements. A second major difference between these two methods is that self-reported age of hypertension onset is always dependent on the then-prevailing definition of hypertension, which has changed from > 180/110 to > 130/80 mmHg over the past seven decades. Objective measurements are therefore likely to be the most accurate method for defining age of hypertension onset and should be used for research purposes. However, hypertension onset age based on self-report has a strong correlation with objectively defined onset age [29] and thereby provides a convenient and practical alternative for clinical practice, where repeated BP measurements across several decades are not usually easily available.

In addition to the diverse methods used for defining age of hypertension onset, studies have also used varying age thresholds for early-onset hypertension. In several reports, early-onset hypertension has been defined as onset at age ≤ 55 years [8, 20•, 21••, 23•]. This age threshold is in accordance with the British hypertension guidelines, which recommend different first-line treatment for patients over and under 55 years of age [30]. In other studies, the participants have been divided into several 10-year age of onset categories mainly based on convenience, i.e., depending on the age range of the study sample [22, 25•, 28••, 29, 31]. In any case, no criterion for standard definitions currently exists for either age of hypertension onset or early-onset hypertension. Additional research is therefore needed on the agreement between age of hypertension onset defined by using different methods. In addition, universal definitions for early-onset hypertension and age of hypertension onset are needed for both research and clinical purposes.

Correlates of Hypertension Onset Age

Only three small studies have assessed the clinical characteristics related to early-onset hypertension in men and women [26, 32, 33]. The first study examined 82 Taiwanese patients who developed hypertension before the age of 40 years [32]. The majority of these patients (56 out of 82) were male and had consistently higher triglyceride levels compared with controls. In addition, male patients had higher body mass index, whereas women had higher uric acid, suggesting gender-specific differences in the correlates of early-onset hypertension. In the second study [33], only nine Japanese students with early-onset hypertension were identified after screening thousands of subjects < 30 years of age at annual university student check-ups. All of these patients were men, and eight out of nine had parents who were treated with antihypertensives, reflecting the genetic predisposition to early-onset hypertension. In an additional third study with no men included in the study sample, women with a hypertensive disorder of pregnancy reported diagnosis of hypertension 7.7 years earlier than women without pregnancy complications [26]. Despite these studies being restricted by their small study samples, at least male sex, higher body mass index, and genetic background appear to be key correlates of early-onset hypertension. Nevertheless, once early-onset hypertension has been established, healthcare providers need to investigate these young patients for secondary causes of hypertension, as recommended by the current guidelines [18, 19]. However, one study has suggested that the prevalence of secondary hypertension could surprisingly be even lower in younger than in older patients [34]. In conclusion, despite these preliminary results, the data are currently too limited to make any robust recommendations on which individuals should be screened for early-onset hypertension in clinical practice.

Age of Hypertension Onset and Hypertension Heritability

Several studies have demonstrated that hypertension onset age is a highly heritable trait. The cumulative incidence of hypertension by parental hypertension status in the Framingham Heart Study Offspring Cohort is shown in Fig. 1 [21••]. In the Framingham and Johns Hopkins Precursors Studies, early-onset hypertension (onset at age ≤ 55 years) in both parents was associated with over 3.4- and 6.2-fold adjusted risks of hypertension in offspring, respectively [20•, 21••]. In contrast, late-onset parental hypertension in both parents, however, carried only non-significant or 1.5-fold risks of hypertension in both studies. Additionally, this heritability effect seems to cross over generations, as early-onset hypertension in grandparents has been demonstrated to predict hypertension also in grandchildren [23•]. Namely, in 3608 third-generation participants of the Framingham Heart Study, risk for hypertension was conferred simultaneously by presence of early-onset hypertension in parents (odds ratio of 2.10) as well as in grandparents (odds ratio of 1.33). These results suggest that a considerable familial susceptibility for hypertension exists, and this predisposition could even cross generations. However, further studies are required to shed light on the mechanisms underlying transgenerational risk for hypertension and its clinical implications.

Fig. 1
figure 1

Cumulative incidence of hypertension in relation to parental age of hypertension onset (from BMJ 2017;357:j1949). Published with the permission of BMJ Publishing Group Ltd.

Full size image

Besides population-based studies, early-onset hypertension has been associated with various single nucleotide polymorphisms in genomic studies [27, 35,36,37,38,39,40,41]. However, no distinct genetic variants or genes have been identified to specifically and consistently link with early-onset hypertension across different study populations. Based on the current evidence, the association between genetic variation and early hypertension onset age seems to vary highly by geographic and ethnic backgrounds [35,36,37,38]. As the precise genetic etiology of early-onset hypertension still remains elusive, additional research in this domain, and particularly on the impact of polygenic risk scores on the age of hypertension onset, is needed.

Age of Hypertension Onset and Disease Risk

Even though hypertension is a commonly known risk factor for myocardial infarction and stroke [42], limited evidence exists on the effects of hypertension onset age on cardiovascular disease risk. Only three previous studies to date have assessed the relation between hypertension onset age and various cardiovascular disease outcomes ([21••, 22, 28••]; Table 1). One of these studies examined the association between hypertension onset age and hypertension-mediated organ damage in 2680 middle-aged participants of the Coronary Artery Risk Development in Young Adults (CARDIA) study [22]. Two studies that were performed in primary care patients (n = 10,313) or in Framingham Heart Study participants (n = 3614) used cardiovascular death and other cardiovascular disease events as the outcome of interest [21••, 28••]. Overall, the results from all these studies consistently demonstrate that hypertension onset at an earlier age, without any clear threshold, is a potent risk factor for both subclinical and subsequent overt cardiovascular disease (Table 1). In addition, the odds of subclinical disease seem to be similar irrespective of whether the age of onset is based on self-report or objective measurements [22, 29]. The risk estimates reported in these studies remained highly significant even after adjusting for other cardiovascular risk factors. However, the study conducted by Buck et al. in the 1980s used only DBP for diagnosing hypertension, and the results were not adjusted for all relevant confounders, such as cholesterol or glucose levels [28••].

Table 1 Age of hypertension onset and odds of adverse outcomes
Full size table

Besides cardiovascular disease risk, two studies have also suggested that age of hypertension onset may be related to risk of developing dementia [24, 25•]. Gilsanz et al. examined the association between hypertension onset age, derived from two serial BP measurements, and incident dementia in 5646 women [24]. In this study, early-onset hypertension was not related to dementia, whereas mid-adulthood hypertension was associated with a 65% increase in risk of dementia. However, the risk estimates were elevated only among women. In another study by Corrada et al., performed in a highly selected cohort of 559 participants aged > 90 years, self-reported hypertension onset at 80–89 years was surprisingly related to a 42% lower risk of dementia, compared with those without hypertension [25•]. The finding was even more notable in those participants with hypertension onset age of 90+ years, as these participants had a 63% lower risk of dementia.

In more focused analyses on sex-specific differences in the CARDIA study, the impact of early-onset hypertension on cardiac effects seems to differ in men and women [31]. In that report, a prominent association of early-onset hypertension with left ventricular diastolic dysfunction (but not hypertrophy) was observed in women, in contrast to a prominent association of early-onset hypertension with increase in left ventricular hypertrophy (but not diastolic dysfunction) in men. It remains unclear if this finding explains the consistently observed female predominance of incident heart failure with preserved ejection fraction in later life, and whether it is a result of the sex differences in BP trajectories over the life course [43, 44].

Taking all available evidence together, it appears that early hypertension onset is associated with a considerable higher risk of cardiovascular disease than late-onset hypertension, most likely mainly representing the increased overall lifetime BP related to early-onset hypertension. Additional studies, however, are still needed to elucidate the potential sex-specific differences in the association between hypertension onset age and cardiovascular outcomes. In addition, the majority of the current evidence is based on case-cohort study designs, and prospective cohort studies in this domain are therefore needed. Finally, findings on the relation of early- versus late-onset hypertension and incident dementia are currently conflicting and scarce.

Age of Hypertension Onset: How to Apply in Practice?

Considering the growing demand of more individualized treatment approaches along with increasing global burden of hypertension, a need for improved and feasible risk stratification methods exists. The potential advantages of assessing age of hypertension onset, instead of solely present, single-occasion BP, in clinical practice are listed in Table 2. Increasing evidence supports taking into consideration the cumulative lifetime burden of BP and other cardiovascular risk factors, instead of only single-occasion measurements, when assessing the risk of cardiovascular disease in patients [8, 45]. Even though several methods and indices have been previously proposed for assessing long-term exposure to high BP [8, 14••, 15, 16], their clinical use has remained limited due to their complexity which limits implementation into clinical practice. In contrast to these more elaborate indices, assessment of hypertension onset age could provide a feasible alternative for quantifying a patient’s lifetime BP load. It could be particularly used for improving cardiovascular risk assessment and BP control in younger patients, who often remain undiagnosed and/or untreated, but still carry a high lifetime cardiovascular disease risk [46, 47]. In addition to cardiovascular risk assessment, information on parental age of hypertension onset can be simultaneously used for assessing the risk of hypertension in offspring. Implementing age of hypertension onset assessment into clinical practice should therefore be used to target both hypertension therapy and screening efforts to those at highest risk.

Table 2 Potential advantages for assessing age of hypertension onset in clinical practice
Full size table

Even though most of the current evidence on the association between age of hypertension onset and cardiovascular risk is based on objective BP measurements, some studies have also successfully used self-report for determining hypertension onset age [20•, 24, 25•, 26, 27, 29]. Considering the challenges related to accessing objective BP data from historical medical records from various healthcare providers, self-reported information on hypertension onset will most likely be the most relevant source of information in clinical practice. Physicians should therefore document the hypertension onset age of their newly diagnosed patients and their patients’ parents to improve hypertension management.

Conclusions

Despite the varying methods used in different studies, current research indicates that early-onset hypertension has a stronger genetic component and is more strongly associated with cardiovascular outcomes compared with late-onset hypertension. However, the level of evidence on the pathogenesis, correlates, and prognosis of early versus late-onset hypertension still remains low, and several aspects in this domain require further study. First, established definitions for age of hypertension onset and early-onset hypertension need to be defined through expert consensus. Second, the genetic and clinical factors that predispose to early onset of hypertension and its transmission through generations need to be studied in detail. Third, most of the evidence on hypertension onset age as a risk factor for health outcomes comes from case-control studies with only cardiovascular outcomes. Additional prospective cohort studies with a wide range of clinical outcomes, such as dementia [24, 25•], are therefore needed. Fourth, a limited number of studies have suggested that sex-specific differences in the development and prognosis of early-onset hypertension exist. These differences need to therefore be studied in larger samples and in patients with various stages of cardiovascular disease.

The current evidence on hypertension onset age is still based on data from a limited number of observational studies. Thus, no definite evidence-based recommendations on its use in clinical practice can be made. Experimental studies that randomize patients to receive various therapies based on hypertension onset age could elucidate which treatment methods are the most effective for various age of onset groups. With accumulating evidence, assessment of hypertension onset age could be used as a feasible method for improving the risk stratification and personalization of therapy in hypertensive patients.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Franklin SS, Gustin W IV, Wong ND, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure: the Framingham heart study. Circulation. 1997;96:308–15. https://doi.org/10.1161/01.CIR.96.1.308.

    CAS  Article  PubMed  Google Scholar 

  2. Cheng S, Xanthakis V, Sullivan LM, Vasan RS. Blood pressure tracking over the adult life course: patterns and correlates in the Framingham heart study. Hypertension. 2012;60:1393–9. https://doi.org/10.1161/HYPERTENSIONAHA.112.201780.

    CAS  Article  PubMed  Google Scholar 

  3. Kaess BM, Rong J, Larson MG, Hamburg NM, Vita JA, Levy D, et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. 2012;308:875–81. https://doi.org/10.1001/2012.jama.10503.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. Delgado J, Bowman K, Ble A, Masoli J, Han Y, Henley W, et al. Blood pressure trajectories in the 20 years before death. JAMA Intern Med. 2018;178:93–9. https://doi.org/10.1001/jamainternmed.2017.7023.

    Article  PubMed  Google Scholar 

  5. Zhou B, Bentham J, Di Cesare M, Bixby H, Danaei G, Cowan MJ, et al. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2017;389:37–55. https://doi.org/10.1016/S0140-6736(16)31919-5.

    Article  Google Scholar 

  6. Zhou B, Danaei G, Stevens GA, Bixby H, Taddei C, Carrillo-Larco RM, et al. Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet. 2019;394:639–51. https://doi.org/10.1016/s0140-6736(19)31145-6.

    Article  Google Scholar 

  7. Allen NB, Siddique J, Wilkins JT, Shay C, Lewis CE, Goff DC, et al. Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age. JAMA. 2014;311:490–7. https://doi.org/10.1001/jama.2013.285122.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  8. Niiranen TJ, Larson MG, McCabe EL, Xanthakis V, Vasan RS, Cheng S. Prognosis of prehypertension without progression to hypertension. Circulation. 2017;136:1262–4. https://doi.org/10.1161/CIRCULATIONAHA.117.029317.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Yano Y, Reis JP, Colangelo LA, Shimbo D, Viera AJ, Allen NB, et al. Association of blood pressure classification in young adults using the 2017 American College of Cardiology/American Heart Association blood pressure guideline with cardiovascular events later in life. JAMA. 2018;320:1774–82. https://doi.org/10.1001/jama.2018.13551.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Huo X, Gao L, Guo L, Xu W, Wang W, Zhi X, et al. Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study. Lancet Diabetes Endocrinol. 2016;4:115–24. https://doi.org/10.1016/S2213-8587(15)00508-2.

    Article  PubMed  Google Scholar 

  11. Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N. Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med. 2011;171:404–10. https://doi.org/10.1001/archinternmed.2011.2.

    CAS  Article  PubMed  Google Scholar 

  12. Hillier TA, Pedula KL. Characteristics of an adult population with newly diagnosed type 2 diabetes-the relation of obesity and age of onset. Diabetes Care. 2001;24:1522–7. https://doi.org/10.2337/diacare.24.9.1522.

    CAS  Article  PubMed  Google Scholar 

  13. Svensson V, Jacobsson JA, Fredriksson R, Danielsson P, Sobko T, Schiöth HB, et al. Associations between severity of obesity in childhood and adolescence, obesity onset and parental BMI: a longitudinal cohort study. Int J Obes. 2011;35:46–52. https://doi.org/10.1038/ijo.2010.189.

    CAS  Article  Google Scholar 

  14. •• Lauer MS, Anderson KM, Levy D. Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol. 1991;18:1287–94. https://doi.org/10.1016/0735-1097(91)90549-OThis was the first study to demonstrate that long-term blood pressure levels may provide incremental value in predicting hypertension-mediated complications over contemporary single occasion blood pressure measurements.

    CAS  Article  PubMed  Google Scholar 

  15. Kishi S, Teixido-Tura G, Ning H, Venkatesh BA, Wu C, Almeida A, et al. Cumulative blood pressure in early adulthood and cardiac dysfunction in middle age: the CARDIA study. J Am Coll Cardiol. 2015;65:2679–87. https://doi.org/10.1016/j.jacc.2015.04.042.

    Article  PubMed  Google Scholar 

  16. Tielemans SMAJ, Geleijnse JM, Menotti A, Boshuizen HC, Soedamah-Muthu SS, Jacobs DR, et al. Ten-year blood pressure trajectories, cardiovascular mortality, and life years lost in 2 extinction cohorts: the Minnesota Business and Professional mMen Study and the Zutphen Study. J Am Heart Assoc. 2015;4:e001378. https://doi.org/10.1161/JAHA.114.001378.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Nuotio J, Suvila K, Cheng S, Langén V, Niiranen T. Longitudinal blood pressure patterns and cardiovascular disease risk. Ann Med. 2020:1–33. https://doi.org/10.1080/07853890.2020.1733648.

  18. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104. https://doi.org/10.1093/eurheartj/ehy339.

    Article  PubMed  Google Scholar 

  19. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71:e127–248. https://doi.org/10.1016/j.jacc.2017.11.006.

    Article  PubMed  Google Scholar 

  20. • Wang N-YY, Young JH, Meoni LA, Ford DE, Erlinger TP, Klag MJ. Blood pressure change and risk of hypertension associated with parental hypertension: the Johns Hopkins precursors study. Arch Intern Med. 2008;168:643–8. https://doi.org/10.1001/archinte.168.6.643In this study, early-onset hypertension in parents was demonstrated to increase the risk of hypertension in offspring more than late-onset parental hypertension.

    Article  PubMed  Google Scholar 

  21. •• Niiranen TJ, McCabe EL, Larson MG, Henglin M, Lakdawala NK, Vasan RS, et al. Heritability and risks associated with early onset hypertension: multigenerational, prospective analysis in the Framingham Heart Study. BMJ. 2017;357. https://doi.org/10.1136/bmj.j1949Objective, serial BP measurements in both parents and children were used to demonstrate that early-onset hypertension is highly heritable and confers an increased risk of cardiovascular mortality compared with late-onset hypertension.

  22. Suvila K, McCabe EL, Lehtonen A, Ebinger JE, Lima JAC, Cheng S, et al. Early onset hypertension is associated with hypertensive end-organ damage already by MidLife. Hypertension. 2019;74:305–12. https://doi.org/10.1161/hypertensionaha.119.13069.

    CAS  Article  Google Scholar 

  23. • Niiranen TJ, McCabe EL, Larson MG, Henglin M, Lakdawala NK, Vasan RS, et al. Risk for hypertension crosses generations in the community: a multi-generational cohort study. Eur Heart J. 2017;38:2300–8. https://doi.org/10.1093/eurheartj/ehx134In this study, early-onset hypertension in grandparents was shown to associate with increased odds of hypertension in grandchildren, even after accounting for parental hypertension status.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Gilsanz P, Mayeda ER, Glymour MM, Quesenberry CP, Mungas DM, DeCarli C, et al. Female sex, early-onset hypertension, and risk of dementia. Neurology. 2017;89:1886–93. https://doi.org/10.1212/WNL.0000000000004602.

    Article  PubMed  PubMed Central  Google Scholar 

  25. • Corrada MM, Hayden KM, Paganini-Hill A, Bullain SS, DeMoss J, Aguirre C, et al. Age of onset of hypertension and risk of dementia in the oldest-old: the 90+ study. Alzheimers Dement. 2017;13:103–10. https://doi.org/10.1016/j.jalz.2016.09.007This study reported that hypertension onset at older ages (> 80 years) could surprisingly be protective against incident dementia, compared with individuals without hypertension.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Heida KY, Franx A, Van Rijn BB, Eijkemans MJC, Boer JMA, Verschuren MWM, et al. Earlier age of onset of chronic hypertension and type 2 diabetes mellitus after a hypertensive disorder of pregnancy or gestational diabetes mellitus. Hypertension. 2015;66:1116–22. https://doi.org/10.1161/HYPERTENSIONAHA.115.06005.

    CAS  Article  PubMed  Google Scholar 

  27. Wilk JB, Djousse L, Arnett DK, Hunt SC, Province MA, Heiss G, et al. Genome-wide linkage analyses for age at diagnosis of hypertension and early-onset hypertension in the HyperGEN study. Am J Hypertens. 2004;17:839–44. https://doi.org/10.1016/j.amjhyper.2004.06.003.

    CAS  Article  PubMed  Google Scholar 

  28. •• Buck C, Baker P, Bass M, Donner A. The prognosis of hypertension according to age at onset. Hypertension. 1987;9:204–8. https://doi.org/10.1161/01.HYP.9.2.204Despite not adjusting for all relevant confounders, this was the first study to show that the prognosis of hypertension could differ according to the age of hypertension onset.

    CAS  Article  PubMed  Google Scholar 

  29. Suvila K, McCabe EL, JAC L, Aittokallio J, Yano Y, Cheng S, et al. Self-reported age of hypertension onset and hypertension-mediated organ damage in middle-aged individuals. Am J Hypertens. 2020. In Press. https://doi.org/10.1093/ajh/hpaa055.

  30. Krause T, Lovibond K, Caulfield M, McCormack T, Williams B. Management of hypertension: summary of NICE guidance. BMJ. 2011;343:d4891. https://doi.org/10.1136/bmj.d4891.

    CAS  Article  PubMed  Google Scholar 

  31. Niiranen TJ, Suvila K, Suppogu N, Ebinger JE, Lima JAC, Bairey Merz CN, et al. Sex differences in the cardiac effects of early-onset hypertension. Hypertension. 2019;74:HYPERTENSIONAHA11913809. https://doi.org/10.1161/HYPERTENSIONAHA.119.13809.

    CAS  Article  Google Scholar 

  32. Chen JW, Wu SY, Pan WH. Clinical characteristics of young-onset hypertension-implications for different genders. Int J Cardiol. 2004;96:65–71. https://doi.org/10.1016/j.ijcard.2003.07.010.

    Article  PubMed  Google Scholar 

  33. Ejima Y, Hasegawa Y, Sanada S, Miyama N, Hatano R, Arata T, et al. Characteristics of young-onset hypertension identified by targeted screening performed at a university health check-up. Hypertens Res. 2006;29:261–7. https://doi.org/10.1291/hypres.29.261.

    Article  PubMed  Google Scholar 

  34. Anderson GH, Blakeman N, Streeten DHP. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens. 1994;12:609–15. https://doi.org/10.1097/00004872-199405000-00015.

    Article  PubMed  Google Scholar 

  35. von Wowern F, Bengtsson K, Lindgren CM, Orho-Melander M, Fyhrquist F, Lindblad U, et al. A genome wide scan for early onset primary hypertension in Scandinavians. Hum Mol Genet. 2003;12:2077–81. https://doi.org/10.1093/hmg/ddg206.

    CAS  Article  Google Scholar 

  36. Chiang KM, Yang HC, Liang YJ, Chen JW, Hwang SM, Ho HY, et al. A three-stage genome-wide association study combining multilocus test and gene expression analysis for young-onset hypertension in Taiwan Han Chinese. Am J Hypertens. 2014;27:819–27. https://doi.org/10.1093/ajh/hpt239.

    CAS  Article  PubMed  Google Scholar 

  37. Porto PI, García SI, Dieuzeide G, González C, Pirola CJ. Renin-angiotensin-aldosterone system loci and multilocus interactions in young-onset essential hypertension. Clin Exp Hypertens. 2003;25:117–30. https://doi.org/10.1081/CEH-120017932.

    CAS  Article  PubMed  Google Scholar 

  38. Yang HC, Liang YJ, Wu YL, Chung CM, Chiang KM, Ho HY, et al. Genome-wide association study of young-onset hypertension in the Han Chinese population of Taiwan. PLoS One. 2009;4:e5459. https://doi.org/10.1371/journal.pone.0005459.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  39. Chiang KM, Yang HC, Pan WH. A two-stage whole-genome gene expression association study of young-onset hypertension in Han Chinese population of Taiwan. Sci Rep. 2018;8:1800. https://doi.org/10.1038/s41598-018-19520-w.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  40. Leu HB, Chung CM, Lin SJ, Chiang KM, Yang HC, Ho HY, et al. Association of circadian genes with diurnal blood pressure changes and non-dipper essential hypertension: a genetic association with young-onset hypertension. Hypertens Res. 2015;38:155–62. https://doi.org/10.1038/hr.2014.152.

    CAS  Article  PubMed  Google Scholar 

  41. Lynn KS, Lu CH, Yang HY, Hsu WL, Pan WH. Construction of gene clusters resembling genetic causal mechanisms for common complex disease with an application to young-onset hypertension. BMC Genomics. 2013;14:1. https://doi.org/10.1186/1471-2164-14-497.

    CAS  Article  Google Scholar 

  42. Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet. 2014;383:1899–911. https://doi.org/10.1016/S0140-6736(14)60685-1.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Ji H, Kim A, Ebinger JE, Niiranen TJ, Claggett BL, Bairey Merz CN, et al. Sex differences in blood pressure trajectories over the life course. JAMA Cardiol. 2020;5:19–26. https://doi.org/10.1001/jamacardio.2019.5306.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Ji H, Kim A, Ebinger JE, Niiranen TJ, Claggett BL, Merz CNB, et al. Cardiometabolic risk-related blood pressure trajectories differ by sex. Hypertension. 2020;75:e6–9. https://doi.org/10.1161/hypertensionaha.119.14570.

    CAS  Article  PubMed  Google Scholar 

  45. Brunner FJ, Waldeyer C, Ojeda F, Salomaa V, Kee F, Sans S, et al. Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium. Lancet. 2019;394:2173–83. https://doi.org/10.1016/S0140-6736(19)32519-X.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  46. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310:959–68. https://doi.org/10.1001/jama.2013.184182.

    CAS  Article  PubMed  Google Scholar 

  47. Sivén SS, Niiranen TJ, Aromaa A, Koskinen S, Jula AM. Social, lifestyle and demographic inequalities in hypertension care. Scand J Public Health. 2015;43:246–53. https://doi.org/10.1177/1403494815571031.

    Article  PubMed  Google Scholar 

Download references

Funding

Open access funding provided by University of Turku (UTU) including Turku University Hospital. K. Suvila was supported by grants from the Aarne Koskelo Foundation, Finnish Foundation for Cardiovascular Research, and Finnish Medical Foundation. T.J. Niiranen was funded by grants from the Academy of Finland (Grant no. 321351), Paavo Nurmi Foundation, Finnish Medical Foundation, and Emil Aaltonen Foundation. V.L. Langén was supported by a grant from the State Research Funding of the Turku University Hospital expert responsibility area. S. Cheng was funded by the National Institute of Health grants R01-HL134168, R01-HL131532, R01-HL143227, and R01-HL142983.

Author information

Authors and Affiliations

  1. Division of Medicine, Turku University Hospital, Turku, Finland

    Karri Suvila & Ville Langén

  2. Department of Internal Medicine, University of Turku, Turku, Finland

    Karri Suvila & Teemu J. Niiranen

  3. Department of Geriatrics, University of Turku, Turku, Finland

    Ville Langén

  4. The Framingham Heart Study, Framingham, MA, USA

    Susan Cheng

  5. Barbra Streisand Women’s Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Susan Cheng

  6. Department of Public Health Solutions, Finnish Institute for Health and Welfare, Turku, Finland

    Teemu J. Niiranen

Authors
  1. Karri Suvila
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ville Langén
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susan Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Teemu J. Niiranen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karri Suvila.

Ethics declarations

Conflict of Interest

The authors report no conflict of interest.

Human and Animal Rights and Informed Consent

All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Prevention of Hypertension: Public Health Challenges

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Suvila, K., Langén, V., Cheng, S. et al. Age of Hypertension Onset: Overview of Research and How to Apply in Practice. Curr Hypertens Rep 22, 68 (2020). https://doi.org/10.1007/s11906-020-01071-z

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11906-020-01071-z

Keywords

  • Blood pressure
  • Hypertension
  • Age of hypertension onset
  • Hypertension heritability
  • Hypertension and cardiovascular disease
  • Clinical implications